Fonar Corporation announced its financial results for the third quarter of fiscal 2025, revealing a 6% increase in Total Revenues-Net to $27.2 million for the quarter ended March 31, 2025, compared to $25.7 million in the same quarter of the previous year. Net Income saw a notable rise of 25%, reaching $3.1 million for the quarter, up from $2.48 million the year before. Additionally, Diluted Net Income Per Common Share Available to Common Stockholders increased by 37% to $0.37 per share from $0.27 per share in the prior year's quarter. Income from Operations experienced a slight decrease of 2%, totaling $3.7 million compared to $3.8 million in the corresponding quarter of the previous year. The company also reported a decrease in Total Cash, Cash Equivalents, and Short-Term Investments by 4%, standing at $54.4 million as of March 31, 2025, down from $56.67 million as of June 30, 2024. Fonar's diagnostic imaging management subsidiary, Health Management Company of America $(HMCA.UK)$, set a new company record by completing 54,612 MRI scans in the third quarter, marking a 2.8% increase from the previous quarter and a 3.4% increase compared to the same quarter in fiscal 2024. Over the nine-month period, HMCA achieved a record 160,780 MRI scans, a 3.9% rise from 154,790 scans in the corresponding period of the previous year.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。